PUBLICATION

ATP Modulates Acute Inflammation In Vivo through Dual Oxidase 1-Derived H2O2 Production and NF-kappaB Activation

Authors
de Oliveira, S., López-Muñoz, A., Candel, S., Pelegrín, P., Calado, A., Mulero, V.
ID
ZDB-PUB-140521-2
Date
2014
Source
Journal of immunology (Baltimore, Md. : 1950)   192(12): 5710-9 (Journal)
Registered Authors
de Oliveira, Sofia, Mulero, Victor
Keywords
none
MeSH Terms
  • Receptors, Purinergic P2Y/immunology
  • Wounds and Injuries/immunology*
  • Inflammation
  • Zebrafish
  • NADPH Oxidases/immunology*
  • Zebrafish Proteins/immunology*
  • Hydrogen Peroxide/immunology*
  • NF-kappa B/immunology*
  • Calcium Signaling/immunology*
  • Adenosine Triphosphate/immunology*
  • Animals
  • Acute Disease
(all 12)
PubMed
24842759 Full text @ J. Immunol.
Abstract
Dual oxidase 1 (Duox1) is the NADPH oxidase responsible for the H2O2 gradient formed in tissues after injury to trigger the early recruitment of leukocytes. Little is known about the signals that modulate H2O2 release from DUOX1 and whether the H2O2 gradient can orchestrate the inflammatory response in vivo. In this study, we report on a dominant-negative form of zebrafish Duox1 that is able to inhibit endogenous Duox1 activity, H2O2 release and leukocyte recruitment after tissue injury, with none of the side effects associated with morpholino-mediated Duox1 knockdown. Using this specific tool, we found that ATP release following tissue injury activates purinergic P2Y receptors, and modulates Duox1 activity through phospholipase C (PLC) and intracellular calcium signaling in vivo. Furthermore, Duox1-derived H2O2 is able to trigger the NF-κB inflammatory signaling pathway. These data reveal that extracellular ATP acting as an early danger signal is responsible for the activation of Duox1 via a P2YR/PLC/Ca(2+) signaling pathway and the production of H2O2, which, in turn, is able to modulate in vivo not only the early recruitment of leukocytes to the wound but also the inflammatory response through activation of the NF-κB signaling pathway.
Genes / Markers
Figures
No images available
Show all Figures
Expression
Phenotype
Fish Conditions Stage Phenotype Figure
i114Tgamputation: caudal fin, chemical treatment: dibenziodolium chlorideProtruding-mouth
i114Tg + MO1-duox + MO4-tp53amputation: caudal finProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: adenosine phosphateProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: dibenziodolium chlorideProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: tetrasodium 5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonateProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: suramin sodiumProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: thapsigarginProtruding-mouth
nz50Tgamputation: caudal fin, chemical treatment: U-73122Protruding-mouth
nz50Tg + MO1-duox + MO4-tp53amputation: caudal finProtruding-mouth
sh235Tgamputation: caudal fin, chemical treatment: adenosine phosphateProtruding-mouth
1 - 10 of 12
Show
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
i114TgTransgenic Insertion
    nz50TgTransgenic Insertion
      sh235TgTransgenic Insertion
        1 - 3 of 3
        Show
        Human Disease / Model
        No data available
        Sequence Targeting Reagents
        Fish
        Antibodies
        Orthology
        Engineered Foreign Genes
        Marker Marker Type Name
        DsRed2EFGDsRed2
        EGFPEFGEGFP
        GFPEFGGFP
        1 - 3 of 3
        Show
        Mapping